NeuroCatch Inc. is a medical device company passionate about improving brain health. Based on science and research, the company is focused on translating leading neuroscience research and scientific innovation into real-world, accessible medical devices. The flagship product, the NeuroCatch® Platform, is a medical device that offers an objective evaluation of cognitive function, delivered in minutes at the point of care.
About
Company Overview
Our Team
Howard Waldner
Executive Board Chair
Pat Doyle
Board Member
Kirk Fisher
Co-Founder
Dr. Ryan D'Arcy
Co‑Founder, Chief Scientific Officer
Derek Norsworthy
Chief Executive Officer
Juan Tomasino
VP of Engineering and Research
Peter Romeo
Chief Commercial Officer
Chris Geyer
Client Technical Support Lead
In addition to our Leadership, Sales, and Customer Care teams listed above, we have a broader team of experts in science, technology, and regulatory fields who are essential to driving innovation and ensuring excellence at NeuroCatch.
NeuroCatch Inc.
Unit 1009, City Centre 3
13761 96 Avenue, Surrey, BC V3V 0E8
Canada
Unit 1009, City Centre 3
13761 96 Avenue, Surrey, BC V3V 0E8
Canada
ARTG number 439393 (Australia) Rx only (US)
The NeuroCatch® Platform is intended to be used in conjunction with other cognitive assessments and is not a diagnostic tool for a specific brain health condition. It is not to be used as a standalone diagnostic device.